New investors join BIOXIS Pharmaceuticals to accelerate development of MTI12, the First Monophasic Tissular inductor
BIOXIS Pharmaceuticals granted ISO 13485 certification for Medical Devices
BIOXIS Pharmaceuticals Labelled Innovative Company of the French Clusters,
Enterprise Innovante des Poles(EIP)
Bioxis pharmaceuticals wins Award for its Regenerative Ultrapure Chitosan
Bioxis pharmaceuticals, CEO meets Russian & Finnish Prime Ministers
